Nitric Oxide and Ovarian Cystic Tumors
Author Information
Author(s): Nomelini Rosekeila Simões, Lívia Carolina de Abreu, Beatriz Martins Tavares-Murta, Sheila Jorge Adad, Eddie Fernando Candido Murta
Primary Institution: Federal University of Triângulo Mineiro
Hypothesis
The study aims to identify differences in iNOS expression and nitric oxide production in patients with varying stages and grades of ovarian cystic tumors.
Conclusion
Increased expression of iNOS and production of nitric oxide metabolites were found in ovarian cancer samples compared to benign and nonneoplastic tissues.
Supporting Evidence
- iNOS expression was higher in malignant tumors compared to benign and nonneoplastic tumors.
- NO metabolite levels were significantly higher in malignant tumors than in benign tumors.
- Well-differentiated carcinomas showed greater iNOS expression than moderately/poorly differentiated carcinomas.
Takeaway
This study looked at how a substance called nitric oxide is made in different types of ovarian tumors, finding that cancerous tumors make more of it than non-cancerous ones.
Methodology
The study involved immunohistochemistry and measurement of nitric oxide metabolites in cystic fluid from tumor samples.
Limitations
The study did not find a significant correlation between NO production and iNOS expression, suggesting other factors may be involved.
Participant Demographics
Participants included 63 women with nonneoplastic (n=15), benign (n=28), and malignant (n=20) ovarian tumors.
Statistical Information
P-Value
P < .05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website